Explore FHI 360

Start a New Search

Search within these results

HIV and AIDS

868 Results Found

Practice Area

Health

For FHI 360, improving the health of the world's women, men and children is core to our mission.
Expertise

HIV and AIDS

FHI 360’s comprehensive approach to fighting HIV and AIDS is driven by innovative research, aggregated evidence and a long track record of engaging directly with communities around the world most impacted by the epidemic.
Event

FHI 360 at AIDS 2022

After two years of focusing on COVID-19, FHI 360 is pleased to join colleagues, partners, advocates, and friends in Montreal at the AIDS 2022 conference to share in the intentional recommitment to fighting the other global epidemic affecting...
Publication

MOSAIC project brief

This project brief describes the objectives and approaches of the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project, introduces the CATALYST study and explains MOSAIC’s vision for women.
Feature

Creating virtual safe spaces for people affected by HIV: FHI 360 and partners provide stigma-free mental health care 

Through the MENA Moves project, FHI 360 and partners in Algeria, Morocco and Tunisia are providing virtual mental health services to people living with HIV.
Feature

Traditional healers partner with FHI 360 to provide HIV services

In the Dominican Republic, FHI 360 and our partners are training traditional healers on how to recognize signs of HIV in their clients and refer them for testing.
Published research

HIV prevalence and incidence among men who have sex with men and transgender women in Bangkok, 2014–2018: Outcomes of a consensus development initiative
Published research

Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana
Published research

Effect of a popular web drama video series on HIV and other sexually transmitted infection testing among gay, bisexual, and other men who have sex with men in Singapore: Community-based, pragmatic, randomized controlled trial
Published research

Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b antibody-mediated prevention randomized trials

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Health

HIV and AIDS

FHI 360 at AIDS 2022

MOSAIC project brief

Creating virtual safe spaces for people affected by HIV: FHI 360 and partners provide stigma-free mental health care

Traditional healers partner with FHI 360 to provide HIV services

HIV prevalence and incidence among men who have sex with men and transgender women in Bangkok, 2014–2018: Outcomes of a consensus development initiative

Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana

Effect of a popular web drama video series on HIV and other sexually transmitted infection testing among gay, bisexual, and other men who have sex with men in Singapore: Community-based, pragmatic, randomized controlled trial

Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b antibody-mediated prevention randomized trials